FDA Drug Application (202414) for IRBESARTAN; HYDROCHLOROTHIAZIDE by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number202414
Product Number003
FormTABLET; ORAL
Dosage300MG; 25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameIRBESARTAN; HYDROCHLOROTHIAZIDE
Active IngredientIRBESARTAN: HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by MACLEODS PHARMS LTD